Gene · 51135
Papers3,419
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
941 to 960 of 3,419
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Role of Bruton's Kinase Inhibitors in Chronic Lymphocytic Leukemia: Current Status and Future Directions. | Cancers (Basel) | 2022 | 35159041 | PubTator, text mining | PubMed |
| Targeting GPCRs and Their Signaling as a Therapeutic Option in Melanoma. | Cancers (Basel) | 2022 | 35158973 | PubTator, text mining | PubMed |
| Small Molecules Targeting PTPσ-Trk Interactions Promote Sympathetic Nerve Regeneration. | ACS Chem Neurosci | 2022 | 35156811 | PubTator, text mining | PubMed |
| Regulation of antiviral innate immunity by chemical modification of viral RNA. | Wiley Interdiscip Rev RNA | 2022 | 35150188 | PubTator, text mining | PubMed |
| IRAK4 exacerbates traumatic brain injury via activation of TAK1 signaling pathway. | Exp Neurol | 2022 | 35149117 | PubTator, text mining | PubMed |
| Ubiquitin-specific proteases in inflammatory bowel disease-related signalling pathway regulation. | Cell Death Dis | 2022 | 35145062 | PubTator, text mining | PubMed |
| Network Pharmacology- and Molecular Docking-Based Identification of Potential Phytocompounds from Argyreia capitiformis in the Treatment of Inflammation. | Evid Based Complement Alternat Med | 2022 | 35140801 | PubTator, text mining | PubMed |
| In silico prediction of HIV-1-host molecular interactions and their directionality. | PLoS Comput Biol | 2022 | 35134057 | PubTator, text mining | PubMed |
| The Long Search for Pharmacologically Useful Anti-Inflammatory Flavonoids and Their Action Mechanisms: Past, Present, and Future. | Biomol Ther (Seoul) | 2022 | 35131949 | PubTator, text mining | PubMed |
| Advances in molecular pathogenesis of hidradenitis suppurativa: Dysregulated keratins and ECM signaling. | Semin Cell Dev Biol | 2022 | 35131152 | PubTator, text mining | PubMed |
| Micro RNAs as potential biomarkers in tuberculosis: A systematic review. | Noncoding RNA Res | 2022 | 35128217 | PubTator, text mining | PubMed |
| MYD88L265P and CD79B double mutations type (MCD type) of diffuse large B-cell lymphoma: mechanism, clinical characteristics, and targeted therapy. | Ther Adv Hematol | 2022 | 35126963 | PubTator, text mining | PubMed |
| Alu RNA Structural Features Modulate Immune Cell Activation and A-to-I Editing of Alu RNAs Is Diminished in Human Inflammatory Bowel Disease. | Front Immunol | 2022 | 35126398 | PubTator, text mining | PubMed |
| [Effect of Celastrol Based on IRAK4/ERK/p38 Signaling Pathway on Proliferation and Apoptosis of Multiple Myeloma Cells]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2022 | 35123623 | PubTator, text mining | PubMed |
| Degraders: The Ultimate Weapon Against Amplified Driver Kinases in Cancer. | Mol Pharmacol | 2022 | 35115411 | PubTator, text mining | PubMed |
| Investigation of the effects of the toll-like receptor 4 pathway on immune checkpoint vista in pancreatic cancer. | Invest New Drugs | 2022 | 35113284 | PubTator, text mining | PubMed |
| A gene expression biomarker for predictive toxicology to identify chemical modulators of NF-κB. | PLoS One | 2022 | 35108274 | PubTator, text mining | PubMed |
| Human genetic and immunological determinants of critical COVID-19 pneumonia. | Nature | 2022 | 35090163 | PubTator, text mining | PubMed |
| Dendritic cell-mediated chronic low-grade inflammation is regulated by the RAGE-TLR4-PKCβ1 signaling pathway in diabetic atherosclerosis. | Mol Med | 2022 | 35062863 | PubTator, text mining | PubMed |
| miR-541-3p Promoted Porcine Reproductive and Respiratory Syndrome Virus 2 (PRRSV-2) Replication by Targeting Interferon Regulatory Factor 7. | Viruses | 2022 | 35062330 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51135/papers?page=48